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Background: Changes in the blood-central nervous system barriers occur under pathological conditions including
inflammation and contribute to central manifestations of various diseases. After short-lasting peripheral and
neurogenic inflammation, the evidence is mixed whether there are consistent blood-spinal cord changes. In the
current study, we examine changes in the blood-spinal cord barrier after intraplantar capsaicin and λ-carrageenan
using several methods: changes in occludin protein, immunoglobulin G accumulation, and fluorescent dye
penetration. We also examine potential sex differences in male and female adult rats.
Results: After peripheral carrageenan inflammation, but not capsaicin inflammation, immunohistochemistry shows
occludin protein in lumbar spinal cord to be significantly altered at 72 hours post-injection. In addition, there is also
significant immunoglobulin G detected in lumbar and thoracic spinal cord at this timepoint in both male and
female rats. However, acute administration of sodium fluorescein or Evans Blue dyes is not detected in the
parenchyma at this timepoint.
Conclusions: Our results show that carrageenan inflammation induces changes in tight junction protein and
immunoglobulin G accumulation, but these may not be indicative of a blood-spinal cord barrier breakdown.
These changes appear transiently after peak nociception and may be indicative of reversible pathology that
resolves together with inflammation.
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The central nervous system (CNS) is separated and pro-
tected from the peripheral environment and blood by
the blood–brain/spinal cord barriers (BBB/BSCB),
homeostatic control mechanisms of specialized micro-
vasculature which include astrocyte endfeet, endothelial
cells, tight junctions, and adherens [1,2]. Various neu-
roinflammatory diseases such as multiple sclerosis, men-
ingitis, Alzheimer’s disease, and ischemia can result
in “breakdown” of the BBB [3]. Pathological conditions
that are shown to disrupt the BSCB include traumatic
spinal cord injury [4], CNS degenerative disorder [5],
CNS inflammation [6], or peripheral nerve injury [7].
Breakdown of the blood-CNS barriers will result in
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reproduction in any medium, provided the orimmune cells from the blood that can contribute to dis-
ease progression and impact drug treatments.
In recent years, the complexity of blood-CNS barriers
has been shown to involve multiple physical barriers and
specific transport components which could potentially
be variably modulated in pathological conditions [8].
Acute stimuli or pathology such as seizures [9], radiation
exposure [10], acute stress [11], drugs [12], or hyper-
thermia [13], can transiently increase the permeability
of the BBB. Early and selective changes prior to disease
onset with specific mechanisms such as rapid activation
of immune cells, for example, mast cells, have also been
identified in various diseases including contusive brain
injury [14], ischemic brain injury [15], and multiple
sclerosis [16].
Peripheral inflammatory stimuli have been shown to
induce “breakdown” of the BSCB in some studies, how-
ever other results have been conflicting. In one study,
carrageenan inflammation induced increased Evans Bluel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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though this was not systematically studied or replicated.
In other studies, complete Freund’s adjuvant (CFA) or car-
rageenan inflammation are apparently not reported to
induce Evans Blue dye leakage at 24 hours post-
administration [18] or at 72 hours post-CFA administra-
tion [19]. However, morphine penetration is apparently
increased specifically in the spinal cord after CFA or
carrageenan at 24 hours post-administration [18]. It has
also been shown that electrical nerve stimulation at
C-fiber intensity or direct application of capsaicin onto the
nerve can cause Evans Blue dye leakage in the entire spinal
cord at 24 hours post-stimulation [20]. However, in
another study, peripherally-injected formalin induces BSCB
changes as evidenced by albumin extravasation beginning
at 4–6 days, but peaking at 7–10 days post-administration
[21] suggesting that this may not be directly related to
nociceptive behaviors or hyperalgesia maintenance. It may
be speculated that changes in the BSCB particularly in
peripheral inflammation may be related to the particular
timepoints, particular mechanisms or sensitivity assessed
by the various methods used, and characteristics of the
animal model. In addition, there may be sex, or strain dif-
ferences in BSCB disruption as seen in some studies in
the brain [22-24] which may affect results in animal
models of inflammatory pain. There has been no study
using multiple methods at different timepoints to assess
changes in the BSCB after peripheral inflammation.
In the current study, we measured changes in the BSCB
after intraplantar capsaicin and carrageenan in both male
and female rats using three different approaches: changes
in morphology of the tight junction protein occludin, en-
dogenous immunoglobulin (IgG) parenchymal perme-
ation, and small size exogenously administered sodium
fluorescein (NaFl) permeation. We used multiple early
and late timepoints after capsaicin and carrageenan in the
hopes of also determining whether changes may be iden-
tified as initiating or maintaining the apparent peripheral
inflammation and expected nociception. Contrary to
expected, we found transient changes using some meth-
ods to assess the blood-spinal cord barrier that occurred
at a later timepoint not associated with peak nociception.
Specifically, our results show changes in spinal occludin
protein morphology and presence of IgG in endothelial
cells and nervous tissue at 72 hours post-carrageenan in
male and female rats, but no major lumbar spinal cord
structural changes or increased penetration of exogen-
ously injected small-molecule fluorescent dye.
Results
Effect of capsaicin and carrageenan on nociception and
spinal tight junction protein occludin
As expected, intraplantar capsaicin induced significant
mechanical hyperalgesia as measured with von Frey hairsin the ipsilateral hindpaw in both male and female rats
(Figures 1A and Figure 1B), as compared to vehicle in-
jection. Two-way repeated measures analysis of variance
(ANOVA) revealed a highly significant effect of group
in male (F3, 100 = 36.7; P< 0.001) and female rats
(F3, 100 = 34.8; P< 0.001). Post hoc analysis showed sig-
nificant differences at all time points tested after capsa-
icin in the ipsilateral hindpaw as compared to vehicle in
male rats (P< 0.05 and P< 0.001 at 2 hours) and at the
2, 3, 4, and 24 hour timepoints after capsaicin in female
rats (P> 0.05 and P< 0.001 at 2 and 3 hours). All ani-
mals injected with capsaicin also showed significant
flinching behaviors for up to 10 minutes post-injection.
Also as expected, intraplantar carrageenan induced sig-
nificant thermal hyperalgesia (Figure 1C and Figure 1D),
as measured by the Hargreaves plantar test and signifi-
cant mechanical hyperalgesia (Figure 1E and Figure 1F),
as measured using the calibrated forceps test in both
male and female rats. For thermal testing, two-way
repeated measures ANOVA revealed a highly significant
effect of group in male (F3, 80 = 40.2; P< 0.001) and fe-
male rats (F4, 80 = 36.2; P< 0.001). Post hoc analysis
showed significant differences at all time points tested
after carrageenan in the ipsilateral hindpaw as compared
to vehicle in male rats (P< 0.05 and P< 0.001 at 3 hours
and 24 hours) and female rats (P< 0.05 and P< 0.001 at
3 hours, 24 hours, and 48 hours). For mechanical testing,
two-way repeated measures ANOVA also revealed
a highly significant effect of group in male (F3, 80 = 32.5;
P< 0.001) and female rats (F3, 80 = 38.7; P< 0.001). Post-
hoc analysis showed significant differences after carra-
geenan as compared to vehicle at all time points tested
in the ipsilateral hindpaw in male rats (P< 0.05 and
P < 0.001 at 3 hours, 24 hours, 48 hours, and 72 hours)
and female rats (P< 0.05 and P< 0.001 at 3 hours,
24 hours, and 48 hours).
Based on the behavioral timecourse, we chose peak
and late timepoints after capsaicin and carrageenan
which would allow us to examine the co-occurence of
nociception and changes in the BSCB. We systematically
examined the morphology of the spinal tight junction
protein occludin in male and female rats at various time-
points. Double immunolabeling for occludin protein and
the endothelial cell marker von Willebrand factor
(VWF) was performed in lumbar spinal cord sections.
We then counted the number of intact occludin protein
overlapping with VWF staining. As a positive control,
intrathecal lipopolysaccharide (LPS) induced clear dis-
turbance of occludin staining with endothelial cells
showing lost or diffuse (“foggy”) staining (Figure 2A).
We then studied if occludin was altered after 1% capsa-
icin inflammation at various timepoints. There was no
apparent disturbed occludin in endothelial cells after
capsaicin treatment at neither 10 minutes, 3 hours,
Figure 1 Intraplantar capsaicin and carrageenan result in significant nociception in both male and female rats. Intraplantar capsaicin
induces significant ipsilateral mechanical hyperalgesia for at least 24 hours post-administration in both male (A) and female (B) rats, as compared
to vehicle injection. Intraplantar carrageenan induces significant ipsilateral heat hyperalgesia and mechanical hyperalgesia in both male (C, E) and
female (D, F) rats, as compared to vehicle injection. Abbreviations: vehicle (VEH), capsaicin (CAP), carrageenan (CARR).
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four ipsilateral/contralateral and dorsal/ventral quad-
rants, a total of 8065 vessels were counted in the 6 male
vehicle/capsaicin/LPS groups (mean of 1344 ± 98.3 per
group) and 5956 vessels in the female vehicle/capsaicin
treatment groups (mean of 1191 ± 58.9 per group) in a
randomized and blinded fashion. In male rats, two-way
ANOVA to analyze the percentage of disturbed occludin
protein in endothelial cells revealed a significant effect
of group (F5, 88 = 59.03; P< 0.001), but not region or
interaction (P> 0.05). The posthoc test showed a signifi-
cant difference between the vehicle group and the intra-
thecal LPS-treated group in all 4 quadrants: the ipsilateral
dorsal, contralateral dorsal and ventral (P< 0.001) and
ipsilateral ventral regions (P> 0.05) (Figure 2C). There
were no significant differences between vehicle and any
of the capsaicin timepoints (P> 0.05). When comparing
capsaicin treatments in females, ANOVA revealed asignificant effect of group (F4, 64 = 15.76; P< 0.05) but no
effect or region or interaction (Figure 2D) (P> 0.05).
However, post-hoc tests did not reveal any significant
differences between groups (P> 0.05). Further individual
group analysis by one-way ANOVA also revealed no sig-
nificant differences between groups within particular
regions (P> 0.05). Hence, it can be concluded that intra-
plantar capsaicin does not induce changes in lumbar
spinal occludin protein.
We then looked at the effect of 3% carrageenan on the
endothelial cell occludin protein at various timepoints in
male and female rats. Here, significant occludin disturb-
ance was noted at the 72 hour timepoint in both male
(Figure 3A) and female (Figure 3B) rats. High mag-
nification pictures show occludin disturbance manifest-
ing as either diffuse/foggy and missing partially or fully
as compared to endothelial cell staining (Figure 3C
and Figure 3D). In order to quantify the occludin
Figure 2 LPS but not intraplantar capsaicin results in significant changes in spinal tight junction protein occludin. Intrathecal LPS
injection (A) but not intraplantar capsaicin (B) induces disturbed occludin morphology in lumbar spinal cord. Number of intact vessels are
significantly decreased in ipsilateral dorsal, ipsilateral ventral, contralateral dorsal, and contralateral ventral spinal cord quadrants after intrathecal
LPS, but not at various timepoints after capsaicin in either male (C) or female (D) rats. Abbreviations: intrathecal (IT), lipopolysaccharide (LPS),
von Willebrand Factor (VWF), occludin (OCC) ipsilateral dorsal (ID), ipsilateral ventral (IV), contralateral dorsal (CD), contralateral ventral (CV), others
as in Figure 1.
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6 male vehicle/carrageenan groups (mean of 1835 ± 231
per group) and 8489 vessels in the 5 female vehicle/
carrageenan groups (mean of 1698 ± 267.5) in a rando-
mized and blinded fashion. Two-way ANOVA of quanti-
fied vessels in male rats revealed a highly significant
effect of group (F5, 120 = 28.35; P< 0.001), but not region
or interaction. The 72 hour post-carrageenan timepoint
was significantly different from vehicle treated group
(P< 0.05) (Figure 3E). In order to confirm that the effect
was due to peripheral hindpaw inflammation rather than
a systemic inflammation, the effect of 3% carrageenan
was also compared when injected subcutaneously in the
dorsum. Here, the number of disturbed occludin vessels
after systemically-administered carrageenan was not
found to be significantly different from vehicle (P> 0.05).
Comparing female rats, two-way ANOVA also revealed a
highly significant effect of group (F4, 84 = 19.85; P< 0.001),
but no effect of region or interaction (P> 0.05). However,
there were no significant differences between vehicle
and any carrageenan treatments (P> 0.05) (Figure 3F).A comparison between the 72 hour timepoint and the
120 hour timepoint revealed a significant difference for
the ipsilateral dorsal region (P< 0.05) but no other com-
parisons, explaining the group effect detected by the
ANOVA. While a trend for decreased intact occludin at
72 hours post-carrageenan similar to the male rats was
noticeable in the female rats, the variability, in general, was
greater particularly in the vehicle-treated animals. There-
fore, we decided to combine the male and female animals
and reanalyzed our data. Again, ANOVA showed a highly
significant effect of group (F5, 224= 20.72; P< 0.001). The
post-hoc test revealed a significant difference only between
the vehicle and the 72 hour post-carrageenan treatment in
the ipsilateral and contralateral dorsal regions (P< 0.05)
(Figure 3G). Hence, occludin protein on endothelial cells
in lumbar dorsal horn is significantly disturbed only at
the 72 hour timepoint after carrageenan, an effect that is
likely to be due to the hindpaw inflammation and not a
systemic inflammatory effect.
We also performed Western Blot staining for occludin
protein from whole lumbar spinal cord. We used the
Figure 3 Intraplantar carrageenan results in significant disrupted spinal occludin in dorsal horn. Intraplantar carrageenan results in the
appearance of disturbed occludin protein at 72 hours post-carrageenan in male (A) and female (B) rats. High magnification pictures show diffuse
occludin staining and missing areas of overlap between occludin and VWF staining in both male (C) and female (D) rats. Blinded quantification
reveals significant reduction of intact ipsilateral dorsal and contralateral dorsal occludin at 72 hrs post-carrageenan in male rats (E), but not in
female rats (F). Pooled male and female groups show significant differences between vehicle and the 72 hour post-carrageenan treatment in
dorsal horn (G). Subcutaneously administered carrageenan away from the hindpaw does not cause alterations in occludin protein.
Abbreviations: subcutaneous (SC), others as in Figures 1 and 2.
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a positive control since this has been previously shown
to show altered occludin protein levels [6]. We con-
firmed a decrease in occludin in the 10 day EAE animals
(data not shown) and also in the intrathecal LPS group
(Figure 4A). However, we could not detect any signifi-
cant differences in occludin protein levels in the 72 hourpost-carrageenan groups. Quantification was performed
by densitometry by pooling male and female groups in
order to increase power and taking the ratio of occludin
to its respective loading control (β-actin) after back-
ground subtraction in the following protein band
regions: total occludin isoforms (~65-79 kDa), lower iso-
forms (~65-70 kDa), and higher isoforms (~70-79 kDa).
Figure 4 Intraplantar carrageenan does not result in significant
reduction in lumbar spinal occludin protein. Intraplantar
carrageenan does not result in the reduction of spinal occludin
protein at 72 hours post-carrageenan in male and female rats as
compared to vehicle, but this is detected after intrathecal LPS. (A).
Densitometric quantification reveals significant decreases in the
occludin/actin ratio after LPS, but not at 72 hours post-carrageenan
as compared to vehicle (B). Abbreviations: female (FEM), others as
in Figures 1, 2, and 3.
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occludin tendency to phosphorylate [6,25] and since the
antibody used is reported to bind to the different
molecular-weight isoforms. One-way ANOVA compari-
son of occludin/actin ratios revealed a significant effect of
group for the total occludin ratios (F3, 27 = 3.34; P< 0.05)
and lower isoforms (F3, 27 = 3.09; P< 0.05). Post-hoc tests
revealed significant differences between intrathecal LPS
and all other groups, but no differences between vehicle
and carrageenan groups (Figure 4B). Taken together, our
results suggest that there are morphological changes in
occludin protein in lumbar spinal quadrants, but no
detectable change in the protein level in the entire
lumbar spinal cord.Intraplantar carrageenan induces IgG extravasation
at 72 hours post-carrageenan
Since a significant occludin disturbance was found at
72 hours post-carrageenan, the effect of intraplantar car-
rageenan was next examined with another method sug-
gestive of BSCB breakdown, IgG extravasation in spinal
cord. By performing a long perfusion with phosphate
buffered saline (PBS) to washout the blood, it was
expected that any IgG in the blood vessels would be
cleared. Double immunolabeling for IgG and WWF was
then performed in lumbar and thoracic spinal sections.
Interestingly, as with occludin disturbance, intraplantar
carrageenan was found to induce significant extravasa-
tion and endothelial cell IgG accumulation only at the
72 hour timepoint in both male (Figure 5A) and female
rats (Figure 5D). High magnification pictures show that
the IgG appears to be mostly located close to the endo-
thelial cell (Figure 5F), although sometimes it was
located outside. In comparing fluorescence intensity
values, one-way ANOVA revealed a significant group ef-
fect for both male (F6, 31 = 2.58; P< 0.05) and female ani-
mals (F5, 28 = 5.48; P< 0.05). Post-hoc tests showed
significant differences between vehicle treatment and the
72 hour timepoint in both male (P< 0.05) (Figure 5B)
and female animals (P< 0.05) (Figure 5E). We also did
not detect significant IgG accumulation at the 24 hour
capsaicin timepoint. In order to ascertain that hindpaw
inflammation itself causes the IgG accumulation and not
the dose used, carrageenan was also administered sub-
cutaneously in the dorsum as in the previous section.
These animals also did not show any significant IgG
accumulations (P> 0.05).
As with the occludin study, IgG appeared to show
effects that were not restricted to the ipsilateral dorsal
horn. Hence, we also searched for IgG accumulation in
the thoracic region and found that it was also present at
the 72 hour post-carrageenan timepoint in several ani-
mals which also had lumbar IgG staining. One-way
ANOVA revealed a non-significant trend group effect
(F6, 28 = 2.3l; P> 0.05), although the post-hoc test revealed
significantly increased fluorescence intensity at 72 hour post-
carrageenan as compared to vehicle (P< 0.05) (Figure 5C).
This suggested a spread of this effect beyond the lumbar
spinal cord, but again not seen with systemically-
administered carrageenan.
In the 72 hour post-carrageenan groups, IgG staining
appeared to be mostly restricted to endothelial cells, as
demonstrated by VWF staining. However, in some cases,
it was clearly present outside the endothelial cells
suggesting some extravasation does occur (Figure 5A
and Figure 5B). We could not systematically detect IgG
inside neurons as we saw in the EAE model (data not
shown), suggesting that extravasation was mild. In order
to search for a common mechanism for BSCB breakdown,
Figure 5 Intraplantar carrageenan induces significant IgG extravasation in spinal cord. Intraplantar carrageenan induces the appearance of
IgG in endothelial cells and nervous tissue at 72 hours post-carrageenan in both male (A) and female (D) rats. Quantification reveals significantly
increased fluorescence intensity in both male (B) and female (E) rats at this timepoint, but not with dorsally-injected subcutaneous carrageenan,
or with capsaicin. Significant IgG is also detected in the thoracic region which correspondingly also peaks at 72 hours post-carrageenan (C). High
magnification picture and triple staining of occludin, VWF, and IgG are shown (F). Endothelial cells with IgG staining show intact occludin protein
within a normal range (G). Abbreviations: Immunoglobulin (IgG), others as in Figures 1, 2, and 3.
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occludin in the 72 hour treated carrageenan male and
female rats (Figure 5G). By selecting vessels that showed
IgG extravasation, we blindly assessed the status of occlu-
din protein (as above) in 206 vessels from 3 male and 3
female rats. While we expected the number of disturbed
occludin protein to be particularly high in these vessels, it
was surprisingly within the range previously measured
with double staining. This suggested to us that occludin
disturbance and IgG accumulation are distinct mechan-
isms which occur independently.
Histological assessment, Evans blue, and sodium
fluorescein dye leakage
We then used other methods to assess the BSCB by
searching for spinal cord structural changes by histo-
logical staining [26] and measuring the extravasation of
intravenously administered small molecule fluorescent
dyes such as Evans Blue and sodium fluorescein (NaFl)
[19,27].
Simple Nissl staining (Figure 6a) and H&E staining
(Figure 6b) were performed on paraformaldehyde (PFA)-
perfused and fixed sections of both male and female
vehicle-injected and 72 hour post-carrageenan rats. Mul-
tiple sections were blindly examined with the help of an
experienced histologist. No major abnormalities were
found between vehicle and carrageenan rats. There was
occasional evidence of swollen perivascular space seen
with Nissl staining. Although not systematically quanti-
fied, this was deemed to be a probable perfusion artifactFigure 6 No major histopathological changes, sodium fluorescein, or
intraplantar carrageenan. H&E staining (A) and Nissl staining (B) do not r
post-carrageenan as compared to vehicle. There is no significant detection
in neither male nor female rats at 72 hours post-carrageenan as compared
significant leakage of dye in lumbar, thoracic, and cervical regions. Abbrevi
cortex (CC), others as in Figures 1, 2, 3, and 4.rather than a change, as it was also seen occasionally on
vehicle injected rats.
In separate rats, NaFl (molecular weight of 376 Dal-
tons) or Evans Blue (molecular weight of 960 Daltons)
dyes were administered intravenously and allowed to cir-
culate for at least 30 minutes under inhalable anaesthe-
sia. Leakage into the parenchyma of lumbar, thoracic,
cervical, midbrain, and cerebral cortex was then quanti-
fied in vehicle-injected, 72 hour post-carrageenan injected
male and female rats, and intrathecal LPS controls. A
clear yellow staining for NaFl or blue staining for Evans
Blue was visually detected in the spinal cord seg-
ments upon removal in LPS injected rats. For Evans Blue,
two-way ANOVA revealed a significant effect of group
(F4, 70 = 5.63; P< 0.05), and region (F4, 70 = 14.1; P< 0.05).
Significant differences were detected by posthoc between
LPS and vehicle groups in the lumbar (P< 0.05), thoracic
(P< 0.001), and cervical (P< 0.05) regions, but not
between vehicle and carrageenan treatment group. A
similar pattern was seen in separate experiments using
NaFl dye injection. Two-way ANOVA of fluorescence
values revealed a highly significant effect of group
(F4, 65 = 28.28; P< 0.001), region (F4, 65 = 7.57; P> 0.05)
and interaction (F16, 65 = 2.38; P> 0.05). Significant differ-
ences detected by posthoc from the LPS and vehicle rats
were seen in the lumbar and thoracic regions (P< 0.001),
also significant in the cervical region (P< 0.05), but not
in brain regions (P> 0.05). There were no significant dif-
ferences at the 72 hour timepoints in neither the male
nor the female carrageenan rats (Figure 5). Similar resultsEvans Blue dye extravasation detected at 72 hours after
eveal major lumbar spinal cord structural abnormalities at 72 hours
of extravasated Evans Blue (C) or NaFL (D) dye in spinal cord or brain
to vehicle treatment. Intrathecal LPS injected animals do show
ations: lumbar (L), thoracic (T), cervical (C), midbrain (MB), cerebral
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rhodamine-based dyes (data not shown). These results
suggested to us that the above methods to assess the
BSCB involve different mechanisms than tight junction
protein or endogenous IgG assessment and emphasizes
the importance for the use of multiple methods to assess
the BSCB after transient pathology. In summary, changes
in spinal occludin and presence of endothelial and/or par-
enchymal IgG can be detected transiently at 72 hours
post-carrageenan, but not fluorescent dye extravasation or
lumbar spinal cord structural changes which may all be
necessary to conclude a “breakdown” in the BSCB.
Discussion
Altered blood-CNS barriers can involve transient and
specific changes with a complex functional effect on per-
meability of endogenous substances, immune cells, or
drug treatments. Alterations in specific mechanisms
such as changes in transporter proteins, tight junctions,
and immune cell penetration can occur quickly in vari-
ous conditions such as stress or xenobiotic exposure
[28-30]. Transient changes are less studied than those
that cause a clear “breakdown” of the BSCB in chronic
diseases, those that can impact the BSCB for weeks and
months such as spinal cord trauma, CNS inflammation,
or peripheral nerve injuries. In the current study,
we studied capsaicin neurogenic inflammation which
induced mechanical hyperalgesia that peaked at about
2–3 hours and lasts for at least 24 hours, and carra-
geenan inflammation which induced mechanical and
heat hyperalgesia that peaked at about 3–24 hours and
lasts for at least 72 hours. Decreased intact occludin
morphology was found in male rats and IgG extravasa-
tion in lumbar and thoracic spinal cord in both male
and female rats. Interestingly, these effects were only
detected at 72 hours post-carrageenan, a late timepoint,
one which is beyond the peak hyperalgesia in this model
and in which the inflammation is subsiding. As we did
not find increased extravasation of exogenously adminis-
tered small size fluorescent dye either Evans Blue or so-
dium fluorescein at ~30 minutes post-administration in
these animals, this suggests that there is no generalized
“breakdown” of the BSCB.
In the first experiments, we found that intact occludin
on endothelial cells was disrupted after intraplantar car-
rageenan administration at 72 hours post-administration
in male rats, but not after capsaicin administration or
subcutaneous carrageenan. Various studies have shown
that the presence of occludin protein determines tight
junction permeability [31,32] and hence its disruption
will influence the BSCB. Several chronic disease models
show decreases in total spinal occludin protein such as
EAE [33], diabetes [34], and nerve injury [19]. Intraplan-
tar carrageenan has been shown to induce a biphasiceffect on radioactive glucose permeability in the brain
which parallels decreases in occludin from isolated
microvessels with a peak at 1–6 hours post carrageenan
and also at 48 hours post-carrageenan [35]. Interestingly,
while we found decreased intact occludin morphology
after carrageenan, we did not find a corresponding
decrease in occludin protein and we also did not find
evidence for a biphasic effect. It is possible that we were
unable to detect changes in specific isoforms. Occludin
has different phosphorylation sites and the highly phos-
phorylated occludin form has been suggested to be the
functional form of the protein [36,37]. Peripheral carra-
geenan has been shown to induce changes in the relative
amount of oligomeric, dimeric, and monomeric isoforms
of occludin associated with brain endothelial cells [25].
However, it is also interesting to note that accumulating
evidence suggests that there may be various differences
between the BBB and BSCB such as, for example, differ-
ences in transporter and occludin expression [38] or
regional differences in penetration of radioactive tracers
and cytokines [39,40]. It would be interesting for future
studies to simultaneously compare the timecourse of
changes in both spinal and brain regions. Nevertheless,
after EAE inflammation, dephosphorylation of spinal
occludin has been shown to coincide with disruption in
occludin morphology [6]. As we did detect decreased
total occludin levels in the spinal inflammation positive
controls, but not carrageenan, this may suggest that
morphological changes may be more sensitive indicators
of early BSCB disruption.
The timing of occludin morphology disturbance 72 hours
after carrageenan was paralleled by the presence of
IgG in endothelial cells and parenchyma. IgG is a large
~150 kDa molecule that under normal conditions does
not cross the BSCB. Its presence in the cerebrospinal fluid
has been labeled as a marker of disease clinically [41].
Various disease models such as apolipoprotein-E knockout
mice [42], rat spinal cord injury [43], and partial
sciatic nerve ligation [19] show IgG accumulation in the
spinal cord. In the superoxide dismutase-1 mutant rat
model of amyotrophic lateral sclerosis, IgG is also
reported in the lumbar spinal cord and cortex, although
interestingly at the pre-symptomatic stage prior to
changes in occludin and increased penetration of Evans
Blue dye [44]. We did detect IgG in the nervous tissue,
although a large part of the IgG appeared to compart-
mentalize or stay within the endothelial cells in the car-
rageenan treated animals. Given that our vehicle-treated
animals did not show IgG and the effect occurred only at
72 hours post-carrageenan, we do not believe that this is
an artifact of perfusion or due to vascular abnormalities.
It would be interesting to speculate that this IgG accu-
mulation in endothelial cells may signal an early change
of the BSCB which does not progress to a more
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detected in the thoracic spinal cord indicating a wide-
spread effect. Evans Blue extravasation after electrical
C-fiber stimulation of the sciatic nerve or after peripheral
nerve injury is also reported to occur in the thoracic
spinal cord [20] and our changes in occludin protein were
not restricted to the ipsilateral dorsal horn. It is also
known that spread of BSCB changes can occur in a
delayed manner after spinal cord injury [45] and that
hyperalgesia can spread beyond the injury site in various
animal models. Although we did not detect significant
contralateral nociception in our animal model, several
potential mechanisms for spreading and secondary hyper-
algesia could also be involved here to explain why
changes would not be restricted to the ipsilateral lumbar
dorsal horn. These include activation of the astrocytic
network, disinhibition, infiltration of immune cells, vol-
ume transmission in the CSF, heterosynaptic long-term
potentiation, involvement of commissural interneurons,
and of descending facilitation [46]. It can also be specu-
lated that there may be a delayed release of a humoral
mediator. However, it should be emphasized that carra-
geenan administered subcutaneously did not induce any
IgG accumulation at 72 hours post-administration.
Hence, it is likely that the peripheral ongoing nature of
the inflammation in the hindpaw tissue is responsible for
the late-occurring IgG extravasation which is clearly dif-
ferent from a systemic or CNS inflammation. Neverthe-
less, it is intriguing to consider how other peripherally
administered agents beyond carrageenan may also have
subtle and spreading CNS effects beyond the usual end-
points measured related to hindpaw nociception and the
lumbar dorsal horn.
Testing the permeability of the BSCB after injection of
the small molecular weight NaFl did not reveal an
increased permeability at the 72 hour post-carrageenan
timepoint in neither male nor female rats. Most studies
on barriers have traditionally used Evans Blue which has
a higher molecular weight than NaFl. Leakage has been
shown to occur as early as 3 days after nerve injury [19]
or 24 hours after capsaicin or sciatic nerve stimulation
[20]. Interestingly, carrageenan was reported to induce
spinal Evans Blue leakage in one study [17], although
neither brain nor spinal cord leakage in another [18]. In
vitro, endothelial cells treated with adrenomedullin show
increased permeability to NaFl, but not Evans Blue [47].
Also in vivo after nerve injury, NaFl shows greater differ-
ences in leakage as compared to Evans Blue [19]. Hence,
sensitivity is likely higher using the NaFl dye. However, it
is also known that NaFl binds to transport proteins such
as organic anion transporter [48,49]. In streptozotocin-
treated diabetic rats, there is increased BBB permeability
as evidenced by increased penetration of radioactive
sucrose and decreased tight junction protein [50], butactually decreased permeability to fluorescein explained
by upregulation of transporters in this model [51].
Increased morphine penetration is also reported in per-
ipheral inflammation which does not coincide with
increased Evan Blue dye penetration [18]. It is interesting
to speculate whether the reported increased systemic
analgesic sensitivity after inflammation for opioids [52]
or other drugs [53] can be due only to changes in the
BSCB as detected in our study.
In addition, we performed hematoxylin/eosin and
Nissl staining in lumbar spinal cord in 72 hour animals.
Previous reports have indicated structural alterations in
the spinal cord after nerve injury [26] and in the brain
with acute stimuli such as hyperthermia and metham-
phetamine administration [54,55]. We did not detect
such extensive changes as in the literature in the 72 hour
post-carrageenan group, and although we did find occa-
sional instances of perivascular edema, this was not
systematically quantified and electron microscopy was
not used in our study. Future comprehensive studies to
quantify the presence of minor structural abnormalities
may be interesting to establish the sensitivity of this
method for detecting more subtle changes in the BSCB.
We hypothesized that we could detect sex differences
in the BSCB. As within the pain literature [56,57], there
are reports of sex differences in the BBB which
prompted us to examine this topic for the first time in
this context. Effects of sodium selenite and antioxidants
are reportedly greater in males than in females which
have greater alterations of BBB permeability in some
models of epilepsy [58,59]. However, other studies show
greater permeability in female mice to selenium as com-
pared to male mice during systemic inflammation [60].
Radio frequency radiation also appears to show BBB dis-
ruption in male rats but not female rats [61]. Interest-
ingly, multiple studies that have found changes in the
BBB after peripheral carrageenan were performed only
in female rats [62,63]. In our study, we detected a signifi-
cant difference in male rats in the occludin study, how-
ever both for male and females in the IgG study. This
appeared to us to be due to greater baseline variability
in females. It is possible that particular estrous cycle
stages may influence occludin morphology. The effect
of lifetime estrogen changes and exogenous estrogen
administration has been speculated to influence BBB
penetration, loss of occludin protein, and appearance of
IgG [23,64]. It would be interesting for future studies to
systematically examine whether particular estrous cycle
phases may alter susceptibility to changes in BSCB.
The timecourse of the changes seen in occludin
morphology and IgG extravasation in our study does not
provide a direct correlation between the initiation or
peak nociception and changes in the BSCB, since carra-
geenan hyperalgesia peaks within a few hours. This is
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ceptive C-fibres of the sciatic nerve causes a widespread
opening of the BSCB prevented by locally applied lido-
caine [20] or the prevention of BBB permeability and
tight junction proteins alteration by bupivacaine nerve
block [63]). Animal models of peripheral inflammatory
pain show specific changes in the BBB which can occur
shortly after the stimulus when nociception is present.
Injection of 5% formalin, 3% carrageenan, or CFA induce
changes in brain tight junction proteins and increased
brain permeability to radioactive sucrose at 1 hour,
3 hours, and 48 hours [35,65,66]. Whereas anti-
inflammatory treatments such as rapamycin or diclofe-
nac reduce blood-CNS barrier breakdown together with
hyperalgesia [62,67], no studies establish BSCB altera-
tions as necessary and sufficient for nociception.
Changes in the BSCB may also be secondary effects non-
specific to nociception and as other indicators of central
inflammation may be dissociable from measurable noci-
ceptive behaviors [68,69]. In the current study, the doses
of capsaicin and carrageenan used were on the high
range as compared to the literature making it unlikely
that lower or more commonly used doses of capsaicin or
carrageenan would have elicited more extensive changes
on the BSCB. If due to the nociceptive barrage, early
effects should be expected in the first synapse of spinal
cord, but we could not detect this with capsaicin or early
after carrageenan. It can also be speculated that changes
detected at 3 days post-carrageenan are not related to
peak nociception in peripheral inflammatory pain, but
perhaps to compensatory “healing” mechanisms. Our
study used multiple methods to assess whether there is
“breakdown” of the barrier and suggests that each
method may detect particular mechanisms involved in
changes in the BSCB.
Conclusion
In summary, we have found evidence of changes in
spinal occludin protein and appearance of IgG around
endothelial cells occurring with a delayed onset after
peripheral inflammation and nociception. These changes
are transient and are not restricted to spinal cord areas
of nociceptive input. We conclude that peripheral
inflammation induces transient changes in the spinal
cord indicative of an altered BSCB but these do not
appear linked directly to nociceptor activation.
Methods
Animals
Male and female Sprague–Dawley rats (175–250 grams)
were used in all experiments and obtained from the
Medical University of Vienna local breeding facility
(Himberg, Austria), except in EAE complex inflamma-
tion where Lewis rats were used (obtained from CharlesRiver, Germany). Rats were housed 4–6 per cage in a
unisex manner under 12/12 light dark cycle at tempera-
tures between 20-25°C and humidity between 40-60%.
Food and water was provided ad libitum. Animals were
handled at least twice prior to use and care was taken to
minimize stress during all experimental procedures. All
experimental procedures were approved by the ethics
committee of the Medical University of Vienna (MUW)
and the Austrian Ministry for Science and Research
(BMWF), and conform to the animal experimentation
standards of the International Association for the Study
of Pain (IASP).
Animal models
Capsaicin (1% sonicated in mild heat in 80% 0.9% NaCl,
10% pure ethanol, 10% Tween-80; Sigma) was injected
into the hindpaw at a volume of 25 μl under inhalable
anaesthesia with oxygen, nitrous oxide (N2O) and iso-
flurane. λ-carrageenan (3% mixed vigorously in NaCl)
was injected into the hindpaw at a volume of 100 μl also
under gas anaesthesia. In some groups, carrageenan was
administered in the nape of neck subcutaneously at the
same volume and dose. As positive controls for spinal
inflammation, LPS was injected intrathecally as per [70]
with a first injection of 2 μg/30 μl followed by a second
injection of 20 μg/30 μl 24 hours later. The animal was
sacrificed 3 hours after the second injection. For the EAE
positive control, male and female Lewis rats were used
as previously described [71] and sacrificed 7–10 days
after induction of complex inflammation.
Behavioral assessment
In the first group of experiments, male and female rats
(n = 6 per group) were injected intraplantar with 1% cap-
saicin or vehicle, and nociception was measured at 1, 2,
3, 4, and 24 hours post injection. Mechanical thresholds
were measured using a set of calibrated Von Frey fila-
ments (Stoelting Europe, Dublin, Ireland) between 0.4
grams and 15 grams with animals standing on a wire
mesh inside clear Plexiglas boxes. The caudal region
behind the ipsilateral footpad was stimulated three times
using a three-second stimulation. A positive response
was counted when a clear hindpaw withdrawal occurred,
not due to movement of the animal. Ascending hairs
were presented in a systematic manner starting with the
2 gram hair. After the first response was obtained, four
additional hairs were presented using the up-down
method based on [72]. The 50% paw withdrawal thresh-
old was then interpolated using the formula: 50% g
threshold = (10[xf +kδ])/10,000, where xf = value (in log
units) of the final von Frey hair used; k= tabular value
(see [72] for pattern of positive/negative responses; and
δ=mean difference (in log units) between stimuli in
each pattern used and stimulation in adjacent areas in
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tested first followed by the ipsilateral paw.
In the second group of experiments, male and female
rats (n = 6 per group) were injected intraplantar with 3%
carrageenan or vehicle, and nociception was measured
at 3, 24, 48, and 72 hours post-injection. Mechanical
thresholds were measured using a calibrated forceps
(Bioseb, Vitrolles, France). Habituated animals were
briefly and lightly restrained in a soft towel inhibiting
visual stimulation. The hindpaw was progressively
squeezed at a rate of approximately 100 g per second.
The mechanical threshold was electronically obtained
when the animal clearly withdraw its hindpaw and/or
vocalized. Three readings per hindpaw for the baseline
and two readings per hindpaw for the timepoints post-
injection were measured with a 10-minute inter-testing
interval. Thermal latencies were measured using the
plantar Hargreaves Apparatus (Stoelting Europe, Dublin,
Ireland). The animals were placed on a heated glass floor
(30°C) and the time latency to hindpaw withdrawal (not
due to movement) was measured with application of the
light source on the region caudal to the foot pads. The
radiant heat intensity was set to an arbitrary value that
elicited a baseline withdrawal latency of about 10–12
seconds at the beginning of the experiment. Three base-
line readings were performed and averaged for analysis.
Thereafter, two readings per hindpaw were averaged for
the timepoints post-injection with a 10 minute inter-
testing interval. The contralateral paw was always tested
first followed by the ipsilateral paw.
Immunohistochemistry
Occludin and VWF staining and quantification
For capsaicin experiments, male (n = 4-6 per group) and
female (n = 4-5) animals were sacrificed at 10 minutes,
3 hours, 24 hours and 72 hours (only in males) after 1%
capsaicin or vehicle injection. For λ-carrageenan experi-
ments, male (n = 5-8 per group) and female (n = 5-6 per
group) animals were sacrificed at 3 hours, 24 hours,
72 hours, and 120 hours (only in males) after
λ-carrageenan or vehicle injection. To collect the spinal
cord, animals were deeply anaesthetized using ether and
decapitated. The spinal cord was removed immediately
using pressure expulsion by injecting cold PBS in the
spinal column at the sacral level using a 18-gauge nee-
dle. Thereafter, the lumbar region was carefully dis-
sected, snap-frozen in isopentane, and stored at −80°C.
14-μm-thick transverse slices of the L5 lumbar region
were sectioned at −20°C and placed on slides. After dry-
ing, slides were fixed in 100% ethanol for 30 minutes at
4°C and then acetone for 3 minutes at −20°C. Thereafter,
slides were washed once with PBS and blocked with 5%
normal donkey serum (NDS) at room temperature for
30 minutes. Sections were then incubated with theprimary antisera mouse anti-occludin (1:1000 dilution in
5% NDS; Invitrogen) and rabbit anti-VWF (1:4000 dilu-
tion in 5% NDS; Sigma-Aldrich) for 1 hour at room
temperature. Afterwards, the sections were washed with
PBS and incubated with the secondary antibodies goat
anti-mouse Cy2 (1:200 in PBS; Jackson Immunore-
search) and donkey anti-rabbit Cy3 (1:400 in PBS;
Jackson Immunoresearch) for 1 hour at room temperature.
After final washing with PBS, slides were coverslipped with
AquatexW (Merck Millipore, Darmstadt, Germany).
To investigate occludin expression, the sections were
analyzed using a fluorescence microscope (Olympus
BX51) and pictures were acquired using a colour fluor-
escence camera (Olympus DP50). Discrete occludin was
counted in every spinal cord quadrant (ipsilateral ven-
tral, ipsilateral dorsal, contralateral ventral, contralateral
dorsal) in comparison to the VWF staining, and the
expression within each vessel was manually classified as
“intact” (clear lines of occludin), “partial” (less than 80%
occludin per vessel), “foggy” (diffuse distribution of
occludin) and “lacking” (no occludin) by an experi-
menter blinded to the sample identity. Between ~60 and
100 vessels per quadrant were randomly counted with
this method.
IgG staining
Male (n = 4-5 per group) and female (n = 4-6 per group)
animals were used that had undergone the following
treatments: vehicle, 3 hours post-carrageenan, 24 hours
post-carrageenan, 72 hours post-carrageenan, 120 hours
post-carrageenan, subcutaneous carrageenan (72 hours
post), and 24 hours post-capsaicin. Rats were deeply
anaesthetized using ether and perfused intracardially at a
rate of ~10 ml/min using a peristaltic pump with 150 ml
oxygenated PBS which was warmed to 37°C. The spinal
cord was then immediately removed by pressure expul-
sion with cold saline and snap-frozen in isopentane and
stored at −80°C. 14-μm-thick transverse slices of the L5
lumbar region and T3 thoracic regions were sectioned
using a cryotome at −20°C. After drying for 1 hour, the
slides were fixed in 100% ethanol for 1 hour at 4°C and
for 3 minutes in acetone at −20°C. After washing with
PBS, they were blocked with 5% NDS in PBS with 0.1%
TritonX-100 for 30 minutes. Sections were then incu-
bated in rabbit anti-VWF (1:4000) and donkey anti-Rat
IgG Cy3 (1:600; Chemicon) over night at 4°C. The sec-
tions were then washed with PBS and incubated for
1 hour at room temperature with the secondary anti-
bodies: donkey anti-rabbit Cy2 (1:200 in PBS) and again
donkey anti-rat IgG Cy3 (1:600 in PBS). Sections were
washed again with PBS and the slides were coverslipped
with mounting medium.
To analyze the IgG staining intensity as a marker for
the BSCB integrity, we used a semi-quantitative method.
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taken at 400X magnification with a fluorescence micro-
scope and colour camera (Olympus BX51 and DP50)
using a consistent exposure time. Three non-consecutive
sections from each of the different groups were blocked
and randomized per experimental session and the
experimenter taking the photographs was blind to the
experimental treatment. For analysis, a consistent colour
threshold was set to subtract the background and the
pictures were binarized using CellD 3.3 (Olympus Soft
Imaging Solutions). The integrated density (area X mean
grey value) of the whole images was measured using
ImageJ software (National Institute of Health) and aver-
aged per group.
Triple staining-occludin, IgG, and VWF
A similar procedure as the IgG/VWF was used. The
antibodies used in this case were primary guinea pig
anti-Occludin (1:10; Hycult Biotech), rabbit anti-VWF
(1:4000) and donkey anti-Rat IgG Cy3 (1:600) overnight
at 4°C. All antibodies were diluted with 0.1% PBST+ 5%
NDS. To investigate a direct correlation between IgG
extravasation and occludin distribution, lumbar sections
from male and female 72 hours post-carrageenan groups
(n = 6) were used and occludin protein in those endo-
thelial cells co-staining with IgG from the ipsilateral dor-
sal regions was classified as above into intact, partial,
foggy, or no staining. 15–40 vessels per animal were
analyzed. Representative pictures of the triple staining
were made with the monochrome fluorescence camera
(Olympus XM10).
Western blot for occludin
Male and female animals (n = 4-8 per group) treated
with either vehicle, 72 hours post-carrageenan, or
72 hours after subcutaneous carrageenan were used in
these experiments. Male intrathecally injected LPS (n = 4
per group), naive and EAE animals were used as control
groups for the assay. Rats were decapitated and the
spinal cord was removed by cold PBS pressure expul-
sion. The lumbar spinal cord (L4-L6) was snap frozen at
−80°C in isopentane and stored at the same temperature
until further processing. Tissue samples were homoge-
nized in Lämmli-buffer including protease inhibitors
(Complete Mini, EDTA-free, Roche), heated to 70°C for
10 minutes, vortexed, heated to 95°C for 5 minutes and
centrifuged for 10 minutes at 4°C and 14.000 g. Superna-
tants were then collected and equal amounts of protein
were size fractioned by SDS-PAGE (8% gel) using the
Mini-Protean 3 Cell- system (Bio-Rad) and transferred
onto a nitrocellulose membrane (Protran, Whatman).
The membrane was placed in blocking buffer, consisting
of dry milk powder and Tween-80 (Sigma) in phosphate
buffered saline for 1 hour and then incubated over nightat 4°C with primary polyclonal antibody to Occludin
(rabbit anti-occludin 1:700, Invitrogen). The expression
of ß-Actin (monoclonal anti-ß-actin 1:700, Sigma) was
used as an internal loading control. All antibodies were
diluted with blocking buffer. The blots were washed
three times for 15 minutes each and then incubated with
peroxidase-conjugated anti-rabbit IgG and peroxidase-
conjugated anti-mouse IgG, respectively, for 2 hours at
room temperature. Secondary antibodies were purchased
from Jackson Immuno Research. After washing the blots
three times for 15 minutes each, the bands were visua-
lized by the Immobilon Western Chemiluminescent
HRP Substrate (Millipore) and detected by the Fluor-S
MultiImager (Bio-Rad). Densitometric quantification of
the bands was performed with the Quantity One soft-
ware (Bio-Rad). Background was subtracted for each
lane, and ratio between β-actin band density and pre-
determined areas of low and high molecular occludin
band density was determined by a blinded experimenter.
Histological staining
Rats were deeply anaesthetized using ether and perfused
intracardially first with 25 ml saline followed by 175 ml
4% PFA at a rate of ~10 ml/min using a peristaltic
pump. The following groups (n = 3-4 per group) were
collected: vehicle male, vehicle female, 72 hours post-
carrageenan male, 72 hours post-carrageenan female,
intrathecal LPS. The entire spinal cord column was dis-
sected and post-fixed in 4% PFA overnight. The spinal
cord was then removed by laminectomy and placed in
20% sucrose overnight, and 30% sucrose for 2 additional
days, prior to being snap-frozen in isopentane and
stored in −80°C until further processing. Frozen 8–
10 μm sections from the lumbar spinal cord were then
cut with a cryostat. Hematoxylin/Eosin and Nissl stain-
ings were performed as per a standardized protocol on
multiple sections per animal. Slides were coverslipped
using EukittW (Sigma-Aldrich, Vienna, Austria).
Evans blue dye and sodium fluorescein penetration assay
Male and female animals (n = 3-6 per group) from the
following groups were used in this assay: vehicle, intra-
plantar carrageenan 72 hours post administration, sub-
cutaneous carrageenan 72 hours post administration,
and intrathecal LPS. Sodium fluorescein (10% in 2 ml/kg)
(Sigma) or Evans Blue dye (3% in 4 ml/kg) (Sigma) was
infused into a cannulated femoral vein and allowed to
circulate for 30–40 minutes while the animal was kept
under isoflurane/N2O anaesthesia. Animals were then
immediately intracardially perfused with ~150 ml saline
at a rate of ~10 ml/min using a peristaltic pump. Spinal
lumbar, spinal thoracic, spinal cervical, midbrain, and
cerebral cortex tissues were collected by cold saline pres-
sure expulsion and dissection.
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genized, extracted in 60% trichloroacetic acid, and cen-
trifuged at 18,000 G for 20 minutes. A standard curve
with NaFl (in 60% trichloroacetic acid) was generated
and fluorescence intensity was measured in supernatants
(in duplicate) using a spectrophotometer at an excitation
wavelength of 420 nm and emission wavelength of
525 nm. For Evans Blue dye measurements, tissues wer-
e weighed and extracted in formamide for 72 hours at
65°C. Tissues were then centrifuged at 18,000G for
20 minutes. A standard curve with Evans Blue dye (in
formamide) was generated and fluorescence intensity
was measured in supernatants (in duplicate) using a
spectrophotometer at a wavelength of 620 nm. All mea-
surements were converted to dye concentration per
tissue weight.
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